Clinical Outcomes After EMR or ESD of Colorectal Neoplasms - A Multicenter Registry

Launched by CHINESE UNIVERSITY OF HONG KONG · Dec 15, 2022

Keywords

ClinConnect Summary

This clinical trial is focused on understanding the outcomes of two types of procedures called EMR (Endoscopic Mucosal Resection) and ESD (Endoscopic Submucosal Dissection) for removing abnormal growths in the colon, known as colorectal neoplasms. The goal is to create a registry, which is a collection of health information, from multiple medical centers to help researchers gather important data about how these procedures work and their effectiveness in treating conditions like colorectal cancer and adenomas (a type of benign tumor).

If you or a loved one is between the ages of 65 and 74 and is scheduled to undergo either EMR or ESD for colorectal lesions, you may be eligible to participate in this trial. While the study is not yet open for recruitment, participants can expect to provide information about their experiences with these procedures, contributing to a better understanding of their outcomes. This information could help improve future treatment options for others facing similar health issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Subjects who undergo EMR or ESD for colorectal lesions.
• Exclusion Criteria:
• • Not applicable.